In the late 1940s, a Lilly service representative sent in a sample of earth from the Philippine Islands. This sample contained an organism that produced a substance that appeared to be effective against a number of bacteria, including some that had proved resistant to other antibiotics. Clinical tests followed, and in 1952, Lilly introduced erythromycin. The broad-spectrum antibiotic was found to be effective against many diseases, including pneumonia and streptococcal infections.Use of this image is restricted to projects related to Destination Indiana. IHS may not reproduce.Eli Lilly and Company - Antibiotics Journe
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.